Navigation Links
IDRI and Chembio Collaborate to Develop a Low-Cost Test for Visceral Leishmaniasis
Date:5/11/2009

global health solutions

IDRI is a Seattle-based not-for-profit organization committed to applying innovative science to the research and development of products to prevent, detect and treat infectious diseases of poverty. By integrating capabilities, IDRI strives to create an efficient pathway bringing scientific innovation from the lab to the people who need it most. For more information, go to www.idri.org.

IDRI has been working on leishmaniasis for more than 15 years, applying its expertise to the development of both vaccines and diagnostics. IDRI is actively developing a therapeutic leishmaniasis vaccine designed to be used in conjunction with chemotherapy. This candidate vaccine is currently being tested in several countries. If successful, both diagnostic and therapeutic tools would complement each other to provide an improved strategy against leishmaniasis.

About Chembio Diagnostics

Chembio Diagnostics, Inc. develops, manufactures, licenses and markets proprietary rapid diagnostic tests in the growing $5 billion point-of-care testing market. Chembio's two FDA PMA-approved, CLIA-waived, rapid HIV tests are marketed in the U.S. by Inverness Medical. Chembio markets its HIV STAT-PAK(R) line of rapid HIV tests internationally to government and donor-funded programs directly and through distributors. Chembio also has rapid tests for veterinary tuberculosis and Chagas disease. In 2007 Chembio received a U.S. patent for its Dual Path Platform (DPP(R)) technology which has significant advantages over lateral-flow technologies. This technology is providing Chembio with a significant pipeline of business opportunities for the development and manufacture of new products based on DPP(R). Headquartered in Medford, NY, with approximately 100 employees, Chembio is licensed by the U.S. Food and Drug Administration (FDA) as well as the U
'/>"/>

SOURCE Infectious Disease Research Institute
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Cleveland Clinic, University Hospitals and MetroHealth Collaborate on Free Medical Clinic May 2-3
2. Cordex Pharma to Collaborate with BG Medicine in a Clinical Study of Heart Failure Biomarkers
3. AORN and Mercy Ships Collaborate to Increase Patient Care Aboard Hospital Ships
4. Clinical Care Options and NAM Selected by the International AIDS Society to Collaborate on Official Online Conference Coverage From Annual Meetings
5. Genstruct and Gene Logic Collaborate on Systems Toxicology
6. Impac Software Collaborates With the National Comprehensive Cancer Network to Improve Patient Care
7. Pharmacy Stakeholder Groups Collaborate to Draft Pharmacy Principles for Health Care Reform
8. Collaborate and Converse on HIMSS E-Prescribing Wiki
9. KPMG and Trintech Collaborate to Enable Bay Area Users Group of Trintech Customers to Optimize Their Investments in Technology and Deliver Improved Performance in Turbulent Economic Times
10. NCCN and SEHA Collaborate to Improve Cancer Care
11. Healthbase Collaborates with WellPoint to Bring Affordable Medical Tourism Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... According to a new market ... II-VI, IV-IV, sapphire), Deposition Technology (CVD, MBE, HVPE, ... Application, and Geography-2013-2020", published by MarketsandMarkets, the market ... 12.63% from 2014 to 2020 and reach $104.55 ... tables and 88 figures spread through 342 pages ...
(Date:7/28/2014)... A St. Jude Children’s Research Hospital ... childhood cancer more than doubled their risk of developing ... follow a heart-healthy lifestyle. The results appear in the ... percent of the 1,598 adult survivors of childhood cancer ... for health risk factors like high blood pressure, abdominal ...
(Date:7/28/2014)... Over the years, many adolescents have been forced to ... pain in their knees. A new PhD study involving ... often carries on: , "We can see from the ... ages of 12 and 19 experience problems with pain ... daily knee pain in the front of the knee," ...
(Date:7/28/2014)... SOPHIE has evaluated the relationship between the type ... in Europe. The results show that countries with ... countries with contradictory policies (Eastern Europe), present higher ... health than men. Health inequalities are especially remarkable ... 27% higher risk of having poor health compared ...
(Date:7/28/2014)... Australia (PRWEB) July 28, 2014 What ... a happier lifestyle can often be a struggle that ... channel, psychic and medium, Lynette Leckie-Clark provides simple how-to ... book “The Magic of You.” With inspiring spiritual affirmations ... you can find empowerment, confidence and motivation for everyday ...
Breaking Medicine News(10 mins):Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 2Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 3Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 4Health News:Unhealthy Habits More than Double Risk of Metabolic Syndrome in Childhood Cancer Survivors 2Health News:Unhealthy Habits More than Double Risk of Metabolic Syndrome in Childhood Cancer Survivors 3Health News:Unhealthy Habits More than Double Risk of Metabolic Syndrome in Childhood Cancer Survivors 4Health News:Many people never grow out of their growing pains 2Health News:Gender inequalities in health: A matter of policies 2Health News:Be Empowered to Achieve Happiness from New Book "The Magic of You" 2
... prime minister Mr. Girija Prasad Koirala, which was scheduled to ... health, but his party sources informed that his condition is ... King Gyanendra Thursday evening, was scheduled to be administered the ... Friday, two hours before parliament convenes after four long years. ...
... groups are demanding the government for new and better breast ... National Institute// for Clinical Excellence rejected two new breast cancer ... the patient groups who were campaigning for access to every ... cheaper medicines in clinical trials. The two drugs were docetaxel ...
... eight-year pupil in southwest China's Sichuan province was confirmed ... ministry said Thursday//. ,The girl, surnamed Sun, from ... of fever and pneumonia April 16. She was being ... ,Investigators reported that poultry deaths occurred in ...
... A study by Dutch researchers suggests that eating foods ... down the risk of developing motor neurone disease by ... Utrecht in the Netherlands report their findings in the ... tracked 132 patients who had potential or definite amyotrophic ...
... offered to GPs after negative publicity over the move resulted ... were responsible for NHS deficits. ,The new GP ... increased by 25 percent. BMA's Dr Mary Church defended the ... being as much as ?100,000 was true for GPs in ...
... of asthma symptoms in people with allergic asthma. Dust mites, ... important cause of allergic reactions. //The proteins present in the ... similar to that of asthma. Hence the development of the ... ,Cytos is a Swiss vaccine company which manufactures this vaccine. ...
Cached Medicine News:
(Date:7/28/2014)... TOKYO , July 28, 2014  ImaginAb, ... Roger Crystal , MD as Vice President of ... Global Business Development Product Acquisition & Licensing team at ... developing business strategy and partnerships in the precision medicine ... partner with biotechnology and pharmaceutical companies across the spectrum ...
(Date:7/28/2014)... July 28, 2014   Cardioxyl Pharmaceuticals, Inc. ... demonstrating that CXL-1427, a novel potential treatment for acute ... volunteers. The company has now initiated dosing of hospitalized ... clinical trial designed to further evaluate the drug,s safety ... The Phase I clinical trial evaluated the safety ...
(Date:7/28/2014)... and NEW PROVIDENCE, N.J. , July ... are invited to meet with Linde,s Healthcare division ... to be held at McCormick Place in ... "Hospitals demand nothing less than complete confidence in ... , Linde,s Healthcare Segment manager. "Linde understands the importance ...
Breaking Medicine Technology:ImaginAb Appoints Roger Crystal, MD as Vice President of Business Development 2Cardioxyl Pharmaceuticals Successfully Completes First Clinical Trial For Heart Failure Drug CXL-1427 2Linde's Healthcare division to display new Hospital Services platform at the national ASHE Conference in Chicago 2
... Sept. 1 /PRNewswire-Asia-FirstCall/ -- ... ... var shortURL ... longUrl, so we need to grab the first one. for (var r in data.results) { first_result = ...
... Insert From Carl Zeiss Meditec -- CLERMONT-FERRAND, France, September 1, 2010 ... ... lpUnit=,PRN,; --> ... = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so ...
Cached Medicine Technology:Yongye International Announces RMB 400 Million Revolving Credit Facilities 2Yongye International Announces RMB 400 Million Revolving Credit Facilities 3Yongye International Announces RMB 400 Million Revolving Credit Facilities 4Yongye International Announces RMB 400 Million Revolving Credit Facilities 5Yongye International Announces RMB 400 Million Revolving Credit Facilities 6Yongye International Announces RMB 400 Million Revolving Credit Facilities 7Yongye International Announces RMB 400 Million Revolving Credit Facilities 8French Laboratoires Thea Acquires the Mydriasert(R) ophthalmic Insert From Carl Zeiss Meditec 2French Laboratoires Thea Acquires the Mydriasert(R) ophthalmic Insert From Carl Zeiss Meditec 3French Laboratoires Thea Acquires the Mydriasert(R) ophthalmic Insert From Carl Zeiss Meditec 4French Laboratoires Thea Acquires the Mydriasert(R) ophthalmic Insert From Carl Zeiss Meditec 5French Laboratoires Thea Acquires the Mydriasert(R) ophthalmic Insert From Carl Zeiss Meditec 6French Laboratoires Thea Acquires the Mydriasert(R) ophthalmic Insert From Carl Zeiss Meditec 7
... Anion traces: chloride (Cl) ≤ 500 mg/kg sulfate (SO ... 500 mg/kg Cd ≤ 5 mg/kg Co ≤ 5 ... Fe ≤ 10 mg/kg K ≤ 5 mg/kg Mg ... 2000 mg/kg Ni ≤ 5 mg/kg Pb ≤ 5 ...
Application: Capable of separating DNA fragments of 50 to 1000 bp on a 3% gel Solubility: water 15 mg/mL, clear, colorless, hot Special grade: for molecular biology Suitab tst: electrophoresis te...
Inquire...
Inquire...
Medicine Products: